Health Catalyst CFO disposes shares for tax withholding

Health Catalyst, Inc. Chief Financial Officer Jason Alger disposed of 26,970 shares of common stock at an average price of $1.6599 per share.

Rhea-AI Filing Summary

Health Catalyst, Inc. Chief Financial Officer Jason Alger disposed of 26,970 shares of common stock at an average price of $1.6599 per share. The shares were sold automatically to cover tax withholding on vested restricted stock units under the company’s equity plans, not as a discretionary trade. After this tax-withholding sale, he holds 741,644 shares directly.

Insider Trade Summary

Exercise Price or Tax Liability: 26,970 shares

Exercise Price or Tax Liability 1 txn

Insider Alger Jason

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	26,970	$1.6599	$45K

Holdings After Transaction: Common Stock — 741,644 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Health Catalyst (HCAT) report for Jason Alger?

Health Catalyst reported that CFO Jason Alger disposed of 26,970 common shares. The transaction was a mandated sale-to-cover to satisfy tax withholding obligations on vested restricted stock units under the company’s equity incentive plans, rather than a discretionary open-market trade.

At what price were Jason Alger’s Health Catalyst (HCAT) shares disposed?

Jason Alger’s 26,970 Health Catalyst shares were disposed at an average price of $1.6599 per share. This price reflects the sale-to-cover transaction executed to fund required tax withholding tied to the vesting of restricted stock units granted under the company’s equity incentive plans.

Why did Health Catalyst (HCAT) CFO Jason Alger dispose of shares in this Form 4?

The shares were disposed solely to cover tax withholding obligations from vesting restricted stock units. The company’s equity plans mandate a “sell to cover” mechanism, so this Form 4 reflects an automatic, non-discretionary transaction rather than a voluntary buy or sell decision by the CFO.

How many Health Catalyst (HCAT) shares does Jason Alger still own after this transaction?

After the tax-withholding disposition of 26,970 shares, Jason Alger directly owns 741,644 Health Catalyst common shares. This remaining balance reflects his continued equity stake following the automatic sale-to-cover required under the company’s equity incentive plan framework for vested restricted stock units.

Does the Health Catalyst (HCAT) Form 4 indicate an open-market sale by the CFO?

The Form 4 does not show a discretionary open-market sale. Instead, it records a mandatory sale-to-cover transaction, where 26,970 shares were automatically sold to satisfy tax withholding obligations connected to the vesting of restricted stock units awarded to the Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 06:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alger Jason

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		F(1)		26,970	D	$1.6599	741,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/Benjamin Landry, as Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.